IRIS
PESCE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.611
NA - Nord America 4.220
EU - Europa 3.379
SA - Sud America 520
Continente sconosciuto - Info sul continente non disponibili 268
AF - Africa 135
OC - Oceania 4
Totale 13.137
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.005
SG - Singapore 1.888
RU - Federazione Russa 1.268
IT - Italia 1.036
CN - Cina 895
VN - Vietnam 871
BR - Brasile 419
HK - Hong Kong 323
DE - Germania 232
FR - Francia 167
BD - Bangladesh 156
FI - Finlandia 128
IE - Irlanda 121
CA - Canada 118
JP - Giappone 106
GB - Regno Unito 93
NL - Olanda 90
IN - India 72
MX - Messico 49
KR - Corea 44
PL - Polonia 43
UA - Ucraina 39
ID - Indonesia 38
AR - Argentina 35
ZA - Sudafrica 33
CI - Costa d'Avorio 31
SE - Svezia 31
PK - Pakistan 28
ES - Italia 26
PH - Filippine 25
IQ - Iraq 24
TH - Thailandia 23
TR - Turchia 21
RO - Romania 18
TW - Taiwan 18
AT - Austria 17
EC - Ecuador 16
VE - Venezuela 13
ET - Etiopia 12
JM - Giamaica 12
LT - Lituania 12
TN - Tunisia 12
CO - Colombia 10
EG - Egitto 10
MA - Marocco 10
PY - Paraguay 10
UZ - Uzbekistan 9
BE - Belgio 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
MY - Malesia 7
CR - Costa Rica 6
OM - Oman 6
PE - Perù 6
SA - Arabia Saudita 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EU - Europa 5
KE - Kenya 5
MD - Moldavia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
GT - Guatemala 4
IL - Israele 4
MN - Mongolia 4
NP - Nepal 4
RS - Serbia 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
GA - Gabon 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PA - Panama 3
SC - Seychelles 3
SV - El Salvador 3
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
RW - Ruanda 2
SN - Senegal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
Totale 12.850
Salva come PNG Salva come JPEG
Città #
Singapore 928
San Jose 559
Ashburn 335
Hong Kong 311
Chandler 306
Moscow 305
Beijing 221
Santa Clara 215
Ho Chi Minh City 212
Naples 211
Hefei 191
Hanoi 187
Council Bluffs 154
Dong Ket 118
Los Angeles 114
New York 109
Tokyo 98
Lauterbourg 90
Rome 89
Dallas 80
The Dalles 77
Millbury 76
Menlo Park 63
Munich 60
Milan 51
Nanjing 51
Des Moines 49
Amsterdam 46
Princeton 46
São Paulo 46
Buffalo 45
Boston 44
Napoli 42
Seattle 39
Redondo Beach 38
Warsaw 37
Seoul 35
Denver 32
Haiphong 32
Turku 32
Frankfurt am Main 31
Jacksonville 29
Lappeenranta 29
Da Nang 28
Helsinki 28
Falkenstein 26
London 26
Orem 26
Montreal 25
Phoenix 25
Dearborn 24
Atlanta 23
Chicago 23
Wilmington 23
Chennai 22
Lawrence 22
Mexico City 22
Nuremberg 22
Houston 20
Toronto 20
Brooklyn 19
Hải Dương 18
Nanchang 18
Johannesburg 17
Rio de Janeiro 16
San Francisco 15
Jakarta 14
Ottawa 14
Shenyang 14
Can Tho 13
Manchester 13
Stockholm 13
Addis Ababa 12
Bari 12
Changsha 12
Curitiba 12
Dublin 12
Hebei 12
Poplar 12
Pune 12
Tianjin 12
Turin 12
Bangkok 11
Bologna 11
Iași 11
Palermo 11
Paris 11
Ankara 10
Bắc Giang 10
Hangzhou 10
Lusciano 10
Belo Horizonte 9
Boardman 9
Florence 9
Redwood City 9
Brasília 8
Catania 8
Düsseldorf 8
Shanghai 8
Tashkent 8
Totale 6.743
Salva come PNG Salva come JPEG
Nome #
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 477
Altered taste perception in patients with gastroesophagealreflux disease 269
The potential of cannabidiol in the COVID‐19 pandemic. 246
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients 238
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 203
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 200
Clinical and nutritional correlates associated with weight changes in achalasia patients and the impact of laparoscopic Heller myotomy 187
Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice 179
Percutaneous endoscopic jejunostomy (PEJ) in patients with dumping syndrome: Evaluation of our center on a series of clinical cases 176
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 168
Nasogastric tube after laparoscopic Heller-Dor surgery: Do you really need it? 163
Eosinophilic esophagitis: From pathophysiology to treatment. 160
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 159
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 157
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 156
Long-Term Functional Results of a Modified Caudal-to-Cranial Approach in Laparoscopic Segmental Left Colectomy for Diverticular Disease 156
Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases 155
Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis 153
Impaired duodenal Palmitoylethanolamide release underlies acid-induced mast cells activation in Functional Dyspepsia 153
Impact of psychological distress and psychophysical wellbeing on posttraumatic symptoms in parents of preterm infants after NICU discharge 151
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 150
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 147
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 146
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 146
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 146
Next-Generation Probiotics for Inflammatory Bowel Disease 144
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 144
Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives 144
Effect of Dewaxed Coffee on Gastroesophageal Symptoms in Patients with GERD: A Randomized Pilot Study 144
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 143
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 143
Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic 142
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 141
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 140
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 139
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 138
Author's reply: “Nutritional evaluations and post-treatment strategies in Achalasia” 137
BITTER TASTE RECEPTOR AGONIST AFFECTS FOOD INTAKEIN HEALTHY SUBJECTS 136
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 134
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 134
Laparoscopic Heller-Dor myotomy in elderly achalasia patients: a single center experience with PSM analysis 133
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 133
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 133
Enteric glia: A new player in inflammatory bowel diseases 132
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 132
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 131
Autoimmune comorbidities in idiopathic achalasia 131
Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome 130
S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells 128
Genetic contribution to motility disorders of the upper gastrointestinal tract. 128
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 128
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2 128
Phytotherapics in COVID19: Why palmitoylethanolamide? 127
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice 126
TASTE ALTERATIONS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 126
THE ENTEROGLIAL-DERIVED S100B PROTEIN CONTROLSHUMAN INTESTINAL EPITHELIAL CELLS DIFFERENTIATION ANDPROLIFERATION VIA RAGE INTERACTION 124
Role of Human Enteroglial Cells in Mediating Pathogenic and Probiotic Bacteria Effects on Intestinal Epithelial Cells 123
PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS 123
Ultramicronized palmitoylethanolamide inhibits NLRP3 inflammasome expression and pro-inflammatory response activated by SARS-CoV-2 spike protein in cultured murine alveolar macrophages 123
Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis 122
Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial 121
CORRELATION BETWEEN HIGH RESOLUTION MANOMETRY PARAMETERS AND SYMPTOMS IN TREATED ACHALASIA PATIENTS 119
Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation 118
ENTEROGLIAL DERIVED-S100B PROTEIN IS INVOLVED IN THE PROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON PATHOGEN-INDUCED NITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 117
RISK FACTORS ASSOCIATED WITH UNDESIRED BMI INCREASE IN GERD PATIENTS 116
REPRODUCIBILITY OF MULTICHANNEL ELECTROGASTROGRAPHY PARAMETERS IN DYSPEPTIC PATIENTS AND HEALTHY CONTROLS 115
PPIS THERAPY NEEDING IN GERD PATIENTS WITH OVERLAPPING IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA 115
Modern Achalasia: Diagnosis, Classification, and Treatment 114
Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action 112
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line 112
INTRA-DUODENAL RELEASE OF A BITTER COMPOUND DECREASES CALORIC INTAKE IN HEALTHY VOLUNTEERS 111
SUBJECTS WITH UNINVESTIGATED IRRITABLE BOWEL SYNDROME HAVE AN ALTERED NUTRIENTS INTAKE 111
Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity 107
Increased prevalence of dysphagia in patients with severe atopic dermatitis candidates to biological therapy: implications for diagnosis and management of T2-related disorders 106
S100B‑p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin‑4 and metalloproteinase‑2 inhibition in C6 glioma cells 106
Pharmacological interventions for pediatric irritable bowel syndrome 104
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice 100
Chicago Classification Version 4.0 Improves Stratification of Ineffective Esophageal Motility Patients into Clinically Meaningful Subtypes: A Two-Center International Study 97
Endocannabinoids-related compounds in gastrointestinal diseases 94
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice 93
Complementary and alterative treatments in functional dyspepsia 91
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? 87
HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system 85
Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome 84
Italian guidelines for the diagnosis and treatment of functional dyspepsia – joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG) 83
Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegeneration 83
The treatment of achalasia patients with esophageal varices: an international study 81
Gastro-esophageal reflux in children 79
inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice 77
Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favoring wtp53 rescue 76
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 74
A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis 73
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms 70
Approach to esophageal absent contractility: can we do better? 68
The Relationship among Neonatal Intensive Care Unit Stressors and Irritable Bowel Syndrome in Parents during their infant stay: the mediating role of Anxiety 68
Beyond the gut: Investigating the mechanism of formation of β-casomorphins in human blood 65
The relationship among NICU stressors and irritable bowel syndrome in parents during their infant stay: the mediating role of anxiety 63
Lathyrus sativus diamine oxidase reduces Clostridium difficile toxin A-induced toxicity in Caco-2 cells by rescuing RhoA-GTPase and inhibiting pp38-MAPK/NF-κB/HIF-1α activation 63
Advances and caveats in modern achalasia management 60
The Overlooked Burden of Atopic Comorbidities in Eosinophilic Esophagitis: Insights from a Real-Life Comprehensive Multidisciplinary Evaluation 59
Totale 12.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022476 0 1 2 10 8 15 9 7 85 53 119 167
2022/2023681 74 62 28 50 78 95 5 70 119 41 42 17
2023/2024600 21 66 87 61 18 49 33 61 18 39 79 68
2024/20253.000 144 134 28 34 89 228 291 222 193 282 1.124 231
2025/20266.751 658 454 627 717 1.046 283 593 444 725 547 342 315
2026/2027550 266 284 0 0 0 0 0 0 0 0 0 0
Totale 13.137